Share Twitter LinkedIn Facebook Email Christopher J. Logothetis, MD of MD Anderson Cancer Center discusses why the LATITUDE study will be practice changing for the treatment of prostate cancer at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar Acute Lymphoblastic Leukemia 5 Mins Read
Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani Acute Lymphoblastic Leukemia 3 Mins Read